Acalabrutinib Interactions
There are 509 drugs known to interact with acalabrutinib, along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 213 are major, 295 are moderate, and 1 is minor.
- View all 509 medications that may interact with acalabrutinib
- View acalabrutinib alcohol/food interactions (1)
- View acalabrutinib disease interactions (5)
Most frequently checked interactions
View interaction reports for acalabrutinib and the medicines listed below.
- Acidophilus Extra Strength (lactobacillus acidophilus)
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Advil Dual Action (acetaminophen / ibuprofen)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Azithromycin Dose Pack (azithromycin)
- Bactrim (sulfamethoxazole / trimethoprim)
- Breztri Aerosphere (budesonide / formoterol / glycopyrrolate)
- Brilinta (ticagrelor)
- Brukinsa (zanubrutinib)
- Caltrate (calcium carbonate)
- Centrum Silver Men's (multivitamin with minerals)
- Cialis (tadalafil)
- Claritin (loratadine)
- Creon (pancrelipase)
- Crestor (rosuvastatin)
- Curcumin 95 (turmeric)
- D3 (cholecalciferol)
- Dulera (formoterol / mometasone)
- Eliquis (apixaban)
- Emla (lidocaine / prilocaine topical)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- Paxlovid (nirmatrelvir / ritonavir)
- PreserVision AREDS 2 (multivitamin with minerals)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zenpep (pancrelipase)
Acalabrutinib alcohol/food interactions
There is 1 alcohol/food interaction with acalabrutinib.
Acalabrutinib disease interactions
There are 5 disease interactions with acalabrutinib which include:
Report options
More about acalabrutinib
- acalabrutinib consumer information
- Compare alternatives
- Reviews (38)
- Side effects
- Dosage information
- During pregnancy
- Drug class: BTK inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Kesimpta
Kesimpta is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Calquence
Calquence (acalabrutinib) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Brukinsa
Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Ibrutinib
Ibrutinib (Imbruvica) is a Bruton's tyrosine kinase inhibitor used for certain blood cancers and ...
Venetoclax
Venetoclax (brand name Venclexta) may be used to treat CLL, SLL, or AML in those aged 75 years or ...
Cyclophosphamide
Cyclophosphamide is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, brain ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
